Latest news
FDA PDUFA Watch: Neurology Decisions to Track Through Late September - NeurologyLiveNeurologyLive · Thu, 06 Aug 2026 14:15:45 GMTFDA Action Update, July 2026: Approval, Acceptances, and Advisory Committee Vote - NeurologyLiveNeurologyLive · Mon, 03 Aug 2026 15:05:04 GMTFDA AdComm Votes Against Recommending Deramiocel Approval, Tazbentetol Shows Durable Cognitive Benefit in AD, Salanersen's FDA Breakthrough Designation Meaning - NeurologyLiveNeurologyLive · Sat, 01 Aug 2026 23:14:57 GMTFDA Advisory Committee Votes Against Deramiocel for DMD Cardiomyopathy - NeurologyLiveNeurologyLive · Wed, 29 Jul 2026 07:00:00 GMT